◀ Back to EGFR
EGFR — HSPG2
Text-mined interactions from Literome
Haugh et al., Biotechnol Bioeng 2000
:
We have formulated a simple mathematical model of a key signaling pathway required for regulated migration of fibroblasts and other cell types : activation of the intracellular enzyme
phospholipase C (PLC) mediated by
epidermal growth factor receptor (EGFR) and a multitude of other transmembrane receptors
Ramadurai et al., Am J Physiol Lung Cell Mol Physiol 2003
:
PLC-gamma activation by
EGFR in fetal lung fibroblasts may be involved in EGF control of lung development
Hassan et al., Regul Pept 2004
(Prostatic Neoplasms) :
The effects of NT on
EGFR/ERK/Akt activation and DNA synthesis were
attenuated by
PLC-inhibitor ( U73122 ), PKC-inhibitors ( bisindolylmaleimide, staurosporine, rottlerin ), MEK inhibitor ( U0126 ) and PI3 kinase inhibitors ( wortmannin, LY 294002 )
Bourguignon et al., J Biol Chem 2006
(Carcinoma, Squamous Cell...) :
Overexpression of the LARG-PDZ domain also functions as a dominant negative mutant ( similar to the
PLC/Ca2+-calmodulin dependent kinase II ( CaMKII ) and
EGFR/MAPK inhibitor effects ) to block HA/CD44 mediated signaling events ( e.g. EGFR kinase activation, Ras/RhoA co-activation, Raf-ERK signaling, PLC epsilon mediated inositol 1,4,5-triphosphate production, intracellular Ca2+ mobilization, CaMKII activity, filamin phosphorylation, and filamin-actin binding ) and to abrogate tumor cell growth/migration ... Taken together, our findings suggest that CD44 interaction with LARG and
EGFR plays a pivotal role in Rho/Ras co-activation,
PLC epsilon-Ca2+ signaling, and Raf/ERK up-regulation required for CaMKII mediated cytoskeleton function and in head and neck squamous cell carcinoma progression
Ou et al., J Biol Chem 2012
(Glioma...) :
Moreover, Migfilin positively modulates the expression and activity of epidermal growth factor receptor, and Migfilin mediated migration and invasion depend on
epidermal growth factor receptor induced
PLC-? and STAT3 signaling pathways
Chen et al., J Cell Biol 1996
:
We used signaling restricted EGFR mutants expressed in receptor-devoid NR6 fibroblast cells to investigate whether
EGFR activation of
PLC causes gelsolin mobilization from the cell membrane in vivo and whether this translocation facilitates cell movement
Yang et al., Biochem Pharmacol 1997
:
Since recent studies suggest that activation of phospholipase C (PLC) could increase the phosphorylation of P-gp, and activation of the
EGFR would also
activate PLC , we investigated whether the effect of epidermal growth factor (EGF) on the phosphorylation of P-gp was mediated through PLC
Van Epps-Fung et al., Endocrinology 1997
:
Activation of
EGFR overexpressing 3T3-L1 adipocytes
leads to a 3.4 +/- 1.2-fold stimulation of
PLC activity over basal levels vs. only 1.06 +/- 0.01-fold stimulation by insulin
Amsler et al., Am J Physiol 1999
:
We report here that tyrosine phosphorylation of
phospholipase C-gamma (PLC-gamma) was
induced only when basolateral
EGFR was activated